Suresh Ramalingam
Publications by Year
Research Areas
Cancer Genomics and Diagnostics, Lung Cancer Treatments and Mutations, Lung Cancer Research Studies, RNA modifications and cancer, Cancer Immunotherapy and Biomarkers
Most-Cited Works
- → Survival After Sublobar Resection versus Lobectomy for Clinical Stage IA Lung Cancer(2015)229 cited
- → Significance of EGFR Protein Expression and Gene Amplification in Non–Small Cell Lung Carcinoma(2006)117 cited
- → Diallyl trisulfide selectively causes Bax‐ and Bak‐mediated apoptosis in human lung cancer cells(2008)76 cited
- → Radiosurgery for the treatment of spinal lung metastases(2006)63 cited
- → Significance of EGFR Protein Expression and Gene Amplification in Non-Small Cell Lung Carcinoma(2005)13 cited
- → Antibody response to SARS-CoV-2 mRNA vaccine in lung cancer patients: Reactivity to vaccine antigen and variants of concern(2022)13 cited
- → First-Line Chemotherapy for Advanced-Stage Non–Small-Cell Lung Cancer: Focus on Docetaxel(2005)8 cited
- → A cross-sectional study to assess the health-related quality of life of patients on haemodialysis in Chennai(2024)5 cited
- → An insight into the mental health needs of the common public of Tamil Nadu, India, subjected to COVID-19 lockdown, a rare unprecedented crisis(2021)4 cited
- → Multivariate Analysis of Survival, Local Control, and Time to Distant Metastases in Patients with Unresectable Non–Small-Cell Lung Carcinoma Treated with 3-Dimensional Conformal Radiation Therapy with or Without Concurrent Chemotherapy(2005)4 cited